Cargando…

Identification of CDCA2 as a Diagnostic and Prognostic Marker for Hepatocellular Carcinoma

OBJECTIVE: Hepatocellular carcinoma (HCC) is one of the most common and malignant tumors with an insidious onset, difficult early diagnosis, and limited therapy options, resulting in a poor prognosis. Cell division cycle associated 2 (CDCA2), also known as Repo-Man, plays an important role in regula...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Zhenjun, Zhang, Yu, Shao, Shuai, Liu, Qi, Li, Yuhan, Du, Xiaoxiao, Zhang, Kun, Zhang, Mengxia, Yuan, Haixia, Yuan, Qiang, Liu, Tong, Gao, Yingtang, Wang, Yijun, Hong, Wei, Han, Tao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517522/ https://www.ncbi.nlm.nih.gov/pubmed/34660326 http://dx.doi.org/10.3389/fonc.2021.755814

Ejemplares similares

CDCA3 is a prognostic biomarker for cutaneous melanoma and is connected with immune infiltration
por: Li, Tianhao, et al.
Publicado: (2023)

CDCA5 regulates proliferation in hepatocellular carcinoma and has potential as a negative prognostic marker
por: Shen, Zhiqing, et al.
Publicado: (2018)

Overexpression of CDCA8 Predicts Poor Prognosis and Promotes Tumor Cell Growth in Prostate Cancer
por: Wan, Shun, et al.
Publicado: (2022)

CDCA1/2/3/5/7/8 as novel prognostic biomarkers and CDCA4/6 as potential targets for gastric cancer
por: Li, Zhaoxing, et al.
Publicado: (2021)

CDCA5 promotes the progression of breast cancer and serves as a potential prognostic biomarker
por: Hu, Hao, et al.
Publicado: (2022)

CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma
por: Wang, Zhihuai, et al.
Publicado: (2021)

CDCA2 Inhibits Apoptosis and Promotes Cell Proliferation in Prostate Cancer and Is Directly Regulated by HIF-1α Pathway
por: Zhang, Yixiang, et al.
Publicado: (2020)

CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma
por: Tan, Jianlong, et al.
Publicado: (2022)

Silencing of CDCA5 inhibits cancer progression and serves as a prognostic biomarker for hepatocellular carcinoma
por: Wang, Jianlin, et al.
Publicado: (2018)

Distinct expression of CDCA3, CDCA5, and CDCA8 leads to shorter relapse free survival in breast cancer patient
por: Phan, Nam Nhut, et al.
Publicado: (2018)

CDCA7 Facilitates Tumor Progression by Directly Regulating CCNA2 Expression in Esophageal Squamous Cell Carcinoma
por: Li, Hongyi, et al.
Publicado: (2021)

Construction of an M2 macrophage-related prognostic model in hepatocellular carcinoma
por: Song, Huangqin, et al.
Publicado: (2023)

Development and Validation of Nomogram for Predicting Survival of Primary Liver Cancers Using Machine Learning
por: Chen, Rui, et al.
Publicado: (2022)

LncRNA-Airn alleviates acute liver injury by inhibiting hepatocyte apoptosis via the NF-κB signaling pathway: LncRNA-Airn alleviates acute liver injury
por: Shao, Shuai, et al.
Publicado: (2022)

Prognostic Value of Peripheral Inflammatory Markers in Preoperative Mucosal Melanoma: A Multicenter Retrospective Study
por: Wang, Yixi, et al.
Publicado: (2019)

Prognostic and Immunological Roles of Cell Cycle Regulator CDCA5 in Human Solid Tumors
por: He, Jing, et al.
Publicado: (2022)

CDCA8 as an independent predictor for a poor prognosis in liver cancer
por: Shuai, Yu, et al.
Publicado: (2021)

CDCA8 induced by NF-YA promotes hepatocellular carcinoma progression by regulating the MEK/ERK pathway
por: Chen, Erbao, et al.
Publicado: (2023)

Prognostic Roles of Blood Inflammatory Markers in Hepatocellular Carcinoma Patients Taking Sorafenib. A Systematic Review and Meta-Analysis
por: Liu, Lixing, et al.
Publicado: (2020)

ABCC6 Knockdown Fuels Cell Proliferation by Regulating PPARα in Hepatocellular Carcinoma
por: Zhao, Zhicong, et al.
Publicado: (2022)

A prognostic signature of cuproptosis and TCA-related genes for hepatocellular carcinoma
por: Zhang, Qi, et al.
Publicado: (2022)

Prognostic role of preoperative inflammatory markers in postoperative patients with colorectal cancer
por: Xiao, Zilong, et al.
Publicado: (2023)

Genome-Wide Methylation Profiling of lncRNAs Reveals a Novel Progression-Related and Prognostic Marker for Colorectal Cancer
por: Lin, Shujuan, et al.
Publicado: (2022)

MAPK10 Expression as a Prognostic Marker of the Immunosuppressive Tumor Microenvironment in Human Hepatocellular Carcinoma
por: Li, Huahui, et al.
Publicado: (2021)

AGTRAP Is a Prognostic Biomarker Correlated With Immune Infiltration in Hepatocellular Carcinoma
por: Liu, Shanshan, et al.
Publicado: (2021)

Comprehensive Analysis of SLC17A9 and Its Prognostic Value in Hepatocellular Carcinoma
por: Kui, Xue-Yan, et al.
Publicado: (2022)

Carbohydrate Sulfotransferase 4 Inhibits the Progression of Hepatitis B Virus-Related Hepatocellular Carcinoma and Is a Potential Prognostic Marker in Several Tumors
por: Zhang, Longshan, et al.
Publicado: (2020)

Prognosticators and Prognostic Nomograms for Leiomyosarcoma Patients With Metastasis
por: Zou, YuChi, et al.
Publicado: (2022)

Prognostic value of CDCA3 in kidney renal papillary cell carcinoma
por: Li, Hao, et al.
Publicado: (2021)

Aurora Kinase A as a Diagnostic and Prognostic Marker of Malignant Mesothelioma
por: Guo, Zhenying, et al.
Publicado: (2021)

The E-Twenty-Six Family in Hepatocellular Carcinoma: Moving into the Spotlight
por: Zhang, Tongyue, et al.
Publicado: (2021)

CXCL5 Has Potential to Be a Marker for Hepatocellular Carcinoma Prognosis and Was Correlating With Immune Infiltrates
por: Nie, Yuan, et al.
Publicado: (2021)

CDCA5 overexpression is an Indicator of poor prognosis in patients with hepatocellular carcinoma (HCC)
por: Tian, Yunhong, et al.
Publicado: (2018)

Prognostic Implication of a Novel Metabolism-Related Gene Signature in Hepatocellular Carcinoma
por: Yuan, Chaoyan, et al.
Publicado: (2021)

Prognostic values of ALDOB expression and (18)F-FDG PET/CT in hepatocellular carcinoma
por: Jia, Wenzhi, et al.
Publicado: (2022)

Pan-cancer analysis identifies CDCA3 as a novel prognostic marker associated with immune infiltration in lung adenocarcinoma through bioinformatics analysis
por: Yang, Hao, et al.
Publicado: (2022)

Hypoxia-Associated Prognostic Markers and Competing Endogenous RNA Co-Expression Networks in Breast Cancer
por: Gong, Peng-Ju, et al.
Publicado: (2020)

Prognostic factors and an innovative nomogram model for patients with hepatocellular carcinoma treated with postoperative adjuvant transarterial chemoembolization
por: Xu, Jing-Xuan, et al.
Publicado: (2023)

KIF22 promotes bladder cancer progression by activating the expression of CDCA3
por: Li, Kai, et al.
Publicado: (2021)

Prognostic value of glycolysis markers in pancreatic cancer: A systematic review and meta-analysis
por: Wang, Chengcheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_b2mjm349sqiv5ruud3o5ud7d87